Tyoktovaya acid | Thiogamma tablets coated. 600 mg 60 pcs.
Special Price
$47.53
Regular Price
$56.00
In stock
SKU
BID461887
Latin name
Thiogamma
Thiogamma
Latin name
Thiogamma
packaging 60 pcs
Indications
Diabetic polyneuropathy.
Contraindications
hypersensitivity to the components of the drug
pregnancy
period of breastfeeding.
Clinical data on the use of Thiogamma in children are not available, therefore, children should not be prescribed the drug.
Use during pregnancy and lactation
Thiogamma is contraindicated in pregnancy. If necessary, use the drug during lactation should stop breastfeeding.
In experimental animal studies, no teratogenic effect of thioctic acid was detected. No similar human studies have been conducted.
There is no data on the excretion of thioctic acid with breast milk.
Composition
1 tablet contains:
Active ingredient:
thioctic acid 600 mg
Excipients:
MCC
lactose
talc
colloidal silicon dioxide
lactose monohydrate
carboxymethyl cellulose sodium srdlkrpgldgr
Dosage and administration
Inside, without chewing, with a small amount of liquid, 300–600 mg (0.5–1 tablets) 1 time per day.
Side effects
From the central nervous system: rarely (after iv administration of the drug) - convulsions, diplopia with rapid administration - increased intracranial pressure.
Allergic reactions: urticaria, systemic reactions (up to anaphylactic shock).
From the digestive system: when taking the drug inside - dyspepsia (including nausea, vomiting, heartburn).
Other: hypoglycemia may develop (due to improved glucose uptake) after rapid iv administration - difficulty breathing (passes on its own).
Overdose
Symptoms: nausea, vomiting, headache.
Treatment: carry out symptomatic therapy. There is no specific antidote.
Storage Conditions
Store in a dark place at a temperature of 15 ° to 25 РC.
active substance
thioctic acid
Conditions granted through pharmacies
In retseptu
lekarstvennaja form
tablets
Dragenofarm Pyushly Apotheker GmbH, Germany
Thiogamma
packaging 60 pcs
Indications
Diabetic polyneuropathy.
Contraindications
hypersensitivity to the components of the drug
pregnancy
period of breastfeeding.
Clinical data on the use of Thiogamma in children are not available, therefore, children should not be prescribed the drug.
Use during pregnancy and lactation
Thiogamma is contraindicated in pregnancy. If necessary, use the drug during lactation should stop breastfeeding.
In experimental animal studies, no teratogenic effect of thioctic acid was detected. No similar human studies have been conducted.
There is no data on the excretion of thioctic acid with breast milk.
Composition
1 tablet contains:
Active ingredient:
thioctic acid 600 mg
Excipients:
MCC
lactose
talc
colloidal silicon dioxide
lactose monohydrate
carboxymethyl cellulose sodium srdlkrpgldgr
Dosage and administration
Inside, without chewing, with a small amount of liquid, 300–600 mg (0.5–1 tablets) 1 time per day.
Side effects
From the central nervous system: rarely (after iv administration of the drug) - convulsions, diplopia with rapid administration - increased intracranial pressure.
Allergic reactions: urticaria, systemic reactions (up to anaphylactic shock).
From the digestive system: when taking the drug inside - dyspepsia (including nausea, vomiting, heartburn).
Other: hypoglycemia may develop (due to improved glucose uptake) after rapid iv administration - difficulty breathing (passes on its own).
Overdose
Symptoms: nausea, vomiting, headache.
Treatment: carry out symptomatic therapy. There is no specific antidote.
Storage Conditions
Store in a dark place at a temperature of 15 ° to 25 РC.
active substance
thioctic acid
Conditions granted through pharmacies
In retseptu
lekarstvennaja form
tablets
Dragenofarm Pyushly Apotheker GmbH, Germany
Submit your review to Earn 10 Reward Points click here to login
Write Your Own Review